zoledronic acid has been researched along with Carcinoma, Oat Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aksoy, S; Arık, Z; Ozdemir, NY; Sendur, MA; Uncu, D; Yaman, S; Zengin, N | 1 |
| Price, N | 1 |
| Kimura, S; Kuroda, J; Maekawa, T; Matsumoto, S; Nogawa, M; Sato, K; Segawa, H; Tanaka, F; Wada, H; Yuasa, T | 1 |
1 trial(s) available for zoledronic acid and Carcinoma, Oat Cell
| Article | Year |
|---|---|
Bisphosphonates to prevent skeletal morbidity in patients with lung cancer with bone metastases.
Topics: Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Diphosphonates; Double-Blind Method; Female; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Morbidity; Prognosis; Zoledronic Acid | 2004 |
2 other study(ies) available for zoledronic acid and Carcinoma, Oat Cell
| Article | Year |
|---|---|
Small cell carcinoma of the urinary bladder with hypercalcemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Carcinoma, Small Cell; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Middle Aged; Treatment Outcome; Urinary Bladder Neoplasms; Zoledronic Acid | 2012 |
Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell lines.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Small Cell; Cell Proliferation; Diphosphonates; Drug Interactions; Imidazoles; Lung Neoplasms; Mice; Mice, Nude; Transplantation, Heterologous; Tumor Cells, Cultured; Zoledronic Acid | 2005 |